Experience
MEDICAL WEIGHT LOSS
Medical weight loss is a new treatment now being offered at Peak Beauty. This personalized, provider-supervised approach to losing weight focuses on long-term health and sustainable results.
It often includes a combination of clinical support, prescription medications, nutritional guidance, and lifestyle coaching to help individuals achieve and maintain their weight loss goals safely and effectively. Unlike fad diets, medical weight loss is rooted in science and tailored to each person’s unique needs.
Several injectable medications are FDA-approved for weight loss, including semaglutide and tirzepatide. These drugs work by targeting specific hormones in the gut to help regulate appetite, decrease food intake, and increase feelings of fullness.
SEMAGLUTIDE
Semaglutide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists.
Semaglutide is a medication that has emerged as a potentially effective option for weight loss in individuals who meet specific criteria. This is because it reduces appetite, slows down the emptying of the stomach, and increases feelings of fullness. It has shown promising results in clinical trials and offers a novel approach to weight management by influencing appetite and metabolism. However, it should be used under the guidance of a healthcare professional, and the benefits and risks should be carefully evaluated on an individual basis.
Additionally, a holistic approach to weight management, including diet and exercise, should be considered alongside medication when seeking sustainable weight loss. Semaglutide is administered once a week by injection.
tirzepatide
Tirzepatide is a medication that belongs to a class of drugs known as GLP-1. By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control.
Tirzepatide has been associated with significant weight loss in clinical trials, and has undergone cardiovascular outcomes trials, providing valuable information on the safety and potential cardiovascular benefits of the drug.
WHat’s the difference?
semaglutide
This once-weekly injection mimics a hormone called GLP-1, which helps regulate blood sugar and appetite. It is approved for adults and children aged 12 and older with obesity or overweight with weight-related health problems.
*Starting at $599/mo.
Tirzepatide
This once-weekly injection is a dual agonist, targeting two hormones (GIP and GLP-1) to regulate appetite and blood sugar. It is approved for adults with obesity. Tirzepatide is a dual-agonist, acting on both GLP-1 and GIP receptors, while semaglutide is a single-agonist.